Application of a real world endpoint to identify and characterize genetic profiles of patients (pts) with poor prognosis in advanced non-small-cell lung cancer (aNSCLC).
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.12006
Abstract: 12006Background: There is an unmet need to identify and characterize pts who rapidly progress on currently available therapies. Recent availability of linked clinico-genomic information offers an o... read more here.
Keywords: real world; characterize genetic; endpoint identify; world endpoint ... See more keywords